Scribe Therapeutics SCTX
NASDAQ SCTX
$16.86 -0.50 (-2.88%)
At close: Nov 11, 2026 · 4:00 PM EST

Scribe Therapeutics (SCTX) EBITDA (2025 - 2026)

Analysis

Scribe Therapeutics (SCTX) EBITDA (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 8.95 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 8.16 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 7.34 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.99 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.20 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 7.05 Bn
10 Scribe Therapeutics 43.14 Mn 143,663.76 - -8.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.80 Mn
Mar 31, 2026 -11.79 Mn
Jun 30, 2025 -10.93 Mn
Mar 31, 2025 -4.81 Mn
API Access

Scribe Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=SCTX&period=max&api_key=YOUR_API_KEY